Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet and Carboplatin in Endometrial Cancer
NCT01100359Phase 2Unknown
- Sponsor
- Medical University of Innsbruck
- Start
- Nov 2007
- Primary completion
- Oct 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in endometrial cancer (EC), sponsored by Medical University of Innsbruck. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01100359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100359.